{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:21:04Z","timestamp":1792668064260,"version":"4.5.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,5,9]],"date-time":"2009-05-09T00:00:00Z","timestamp":1241827200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Maxillofac Surg"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1007\/s10006-009-0159-3","type":"journal-article","created":{"date-parts":[[2009,5,8]],"date-time":"2009-05-08T01:45:39Z","timestamp":1241747139000},"page":"87-93","source":"Crossref","is-referenced-by-count":8,"title":["Organ preservation treatment using TPF\u2014a pilot study in patients with advanced primary and recurrent cancer of the oral cavity and the maxillary sinus"],"prefix":"10.1007","volume":"13","author":[{"given":"Adorj\u00e1n F.","family":"Kov\u00e1cs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Eberlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"H\u00fclsmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,5,9]]},"reference":[{"key":"159_CR1","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJM199106133242402","volume":"324","author":"Department of Veterans Affairs Laryngeal Cancer Study Group","year":"1991","unstructured":"Department of Veterans Affairs Laryngeal Cancer Study Group (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685\u20131690","journal-title":"N Engl J Med"},{"key":"159_CR2","author":"MR Posner","year":"2009","unstructured":"Posner MR, Norris CM, Wirth LJ, Shin DM, Cullen KJ, Winquist EW, Blajman CR, Mickiewicz EA, Frenette GP, Plinar LF, Cohen RB, Steinbrenner LM, Freue JM, Gorbunova VA, Tjulandin SA, Raez LE, Adkins DR, Tishler RB, Roessner MR, Haddad RI, for the TAX 324 Study Group (2009) Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation. Ann Oncol . doi: 10.1093\/annonc\/mdn752","journal-title":"Ann Oncol"},{"issue":"18","key":"159_CR3","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1200\/JCO.2006.08.057","volume":"24","author":"J Bourhis","year":"2006","unstructured":"Bourhis J, Lapeyre M, Tortochaux J, Rives M, Aghili M, Bourdin S, Lesaunier F, Benassi T, Lemanski C, Geoffrois L, Lusinchi A, Verrelle P, Bardet E, Julieron M, Wibault P, Luboinski M, Benhamou E (2006) Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: a GORTEC trial. J Clin Oncol 24(18):2873\u20132878","journal-title":"J Clin Oncol"},{"key":"159_CR4","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMoa070956","volume":"357","author":"MR Posner","year":"2007","unstructured":"Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E, Gorbounova V, Tjulandin S, Shin DM, Cullen K, Ervin TJ, Murphy BA, Raez LE, Cohen RB, Spaulding M, Tishler RB, Roth B, Viroglio Rdel C, Venkatesan V, Romanov I, Agarwala S, Harter KW, Dugan M, Cmelak A, Markoe AM, Read PW, Steinbrenner L, Colevas AD, Norris CM Jr, Haddad RI, TAX 324 Study Group (2007) Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 357:1705\u20131715","journal-title":"N Engl J Med"},{"key":"159_CR5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ijrobp.2003.10.055","volume":"59","author":"MG Ghi","year":"2004","unstructured":"Ghi MG, Paccagnella A, D'Amanzo P, Mione CA, Fasan S, Paro S, Mastromauro C, Carnuccio R, Turcato G, Gatti C, Pallini A, Nascimben O, Biason R, Oniga F, Medici M, Rossi F, Fila G (2004) Neoadjuvant docetaxel, cisplatin, 5-fluorouracil before concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck versus concomitant chemoradiotherapy: a phase II feasibility study. Int J Radiat Oncol Biol Phys 59:481\u2013487","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"159_CR6","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa071028","volume":"357","author":"JB Vermorken","year":"2007","unstructured":"Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M, Stewart JS, Jelic S, Betka J, Preiss JH, van den Weyngaert D, Awada A, Cupissol D, Kienzer HR, Rey A, Desaunois I, Bernier J, Lefebvre JL, EORTC 24971\/TAX 323 Study Group (2007) Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 357:1695\u20131704","journal-title":"N Engl J Med"},{"key":"159_CR7","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s10006-006-0684-2","volume":"10","author":"AF Kov\u00e1cs","year":"2006","unstructured":"Kov\u00e1cs AF, Eberlein K, Smolarz A, Weidauer S, Rohde S (2006) Organ-preserving treatment in inoperable patients with primary oral and oropharyngeal carcinoma: chances and limitations. Mund Kiefer Gesichtschir 10:168\u2013177","journal-title":"Mund Kiefer Gesichtschir"},{"key":"159_CR8","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649\u2013655","journal-title":"Am J Clin Oncol"},{"key":"159_CR9","volume-title":"UICC: TNM classification of malignant tumours","year":"1997","unstructured":"Sobin LH, Wittekind C (eds) (1997) UICC: TNM classification of malignant tumours. Wiley, New York"},{"key":"159_CR10","unstructured":"NCI (2003) Common terminology criteria for adverse events version 3.0. http:\/\/ctep.info.nih.gov"},{"key":"159_CR11","first-page":"585","volume":"26","author":"M Baghi","year":"2006","unstructured":"Baghi M, Hambek M, Wagenblast J, May A, Gstoettner W, Knecht R (2006) A phase II trial of docetaxel, cisplatin and 5-fluorouracil in patients with recurrent squamous cell carcinoma of the head and neck (SCCHN). Anticancer Res 26:585\u2013590","journal-title":"Anticancer Res"},{"key":"159_CR12","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.oraloncology.2005.12.006","volume":"42","author":"AD Rapidis","year":"2006","unstructured":"Rapidis AD, Trichas M, Stavrinidis E, Roupakia A, Ioannidou G, Kritselis G, Liossi P, Giannakouras G, Douzinas EE, Katsilieris I (2006) Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up. Oral Oncol 42:675\u2013684","journal-title":"Oral Oncol"},{"key":"159_CR13","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00000421-200210000-00013","volume":"25","author":"WL Barrett","year":"2002","unstructured":"Barrett WL, Gleich L, Wilson K, Gluckman J (2002) Organ preservation with interstitial radiation for base of tongue cancer. Am J Clin Oncol 25:485\u2013488","journal-title":"Am J Clin Oncol"},{"key":"159_CR14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1200\/JCO.2005.04.017","volume":"23","author":"SG Urba","year":"2005","unstructured":"Urba SG, Moon J, Giri PG, Adelstein DJ, Hanna E, Yoo GH, Leblanc M, Ensley JF, Schuller DE (2005) Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a Southwest Oncology Group Trial. J Clin Oncol 23:88\u201395","journal-title":"J Clin Oncol"},{"key":"159_CR15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.otc.2004.10.016","volume":"38","author":"P Han","year":"2005","unstructured":"Han P, Hu K, Frank DK, Sessions RB, Harrison LB (2005) Management of cancer of the base of tongue. Otolaryngol Clin North Am 38:75\u201385","journal-title":"Otolaryngol Clin North Am"},{"key":"159_CR16","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.otohns.2006.12.018","volume":"136","author":"K Shiga","year":"2007","unstructured":"Shiga K, Yokoyama J, Hashimoto S, Saijo S, Tateda M, Ogawa T, Watanabe M, Kobayashi T (2007) Combined therapy after superselective arterial cisplatin infusion to treat maxillary squamous cell carcinoma. Otolaryngol Head Neck Surg 136:1003\u20131009","journal-title":"Otolaryngol Head Neck Surg"}],"container-title":["Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10006-009-0159-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10006-009-0159-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10006-009-0159-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T03:06:36Z","timestamp":1559099196000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10006-009-0159-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,9]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["159"],"URL":"https:\/\/doi.org\/10.1007\/s10006-009-0159-3","relation":{},"ISSN":["1865-1550","1865-1569"],"issn-type":[{"value":"1865-1550","type":"print"},{"value":"1865-1569","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,9]]}}}